Otipax (Lidocaine Hydrochloride)

Lidocaine Hydrochloride, the active ingredient in Otipax, is a local anesthetic presented as a 5 mg/5 g (approx.) topical formulation for otic (ear) use. It relieves pain and discomfort associated with minor ear conditions in adults and children. GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otipax is a topical local anesthetic that provides symptomatic relief in ear‑related conditions.

- Ear pain (otalgia): temporary reduction of pain associated with minor ear canal irritation. - Ear wax blockage (cerumen impaction): facilitates comfortable examination or removal by reducing discomfort. - Post‑procedural ear discomfort: eases mild pain after otoscopic procedures or minor ear surgeries. - Minor external ear infections (otitis externa) adjunct: used alongside antimicrobial therapy to lessen pain. - Swelling of the ear pinna or conduit by reducing local sensitivity to touch and pressure.

Lidocaine applied to the ear is generally well‑tolerated, but local reactions can occur.

Common Side Effects: - Mild itching or burn at the application site. - Transient redness or erythema of the skin. - Slight tingling or pins‑and‑needles sensation. - Minor swelling or edema of the ear canal.

Serious or Rare Side Effects: - Allergic reaction including hives, swelling of the face or throat, or difficulty breathing. - Persistent numbness or loss of sensation beyond the intended area. - Severe skin irritation or ulceration at the site of application. - Systemic toxicity signs such as dizziness, ringing in the ears, or cardiac irregularities (very rare with topical use).

When using Otipax, follow these safety considerations:

- Contraindication: Do not apply if there is a known allergy to lidocaine or other amide‑type local anesthetics. - Assessment: Verify that the ear canal is intact and not perforated before application. - Duration: Limit use to the period recommended by a healthcare professional, typically not exceeding several days. - Pediatric Use: Use only under professional guidance for children, with attention to dosage form size. - Interaction: Avoid concurrent use with other topical ear medications unless directed by a clinician. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lidocaine may interact with other agents applied to the ear or absorbed systemically.

Major Interactions (Avoid): - Other topical anesthetics: combined use can increase risk of local toxicity. - Systemic anti‑arrhythmic drugs (e.g., quinidine, procainamide): may potentiate cardiac effects if significant systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Topical antibiotics or steroids: monitor for altered absorption or reduced efficacy. - CYP450 inhibitors (e.g., amiodarone): may slow lidocaine metabolism if systemic exposure rises. - High‑dose oral analgesics: watch for additive central nervous system depression. - Herbal preparations containing menthol or camphor: may increase local irritation.